title: ASHP guidelines on preventing medication errors with chemotherapy and biotherapy.
authors.affiliation: Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health.
authors.forename: Barry
authors.initials: B
authors.lastname: Goldspiel
authors.affiliation: Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health.
authors.forename: James M
authors.initials: JM
authors.lastname: Hoffman
authors.affiliation: Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health.
authors.forename: Niesha L
authors.initials: NL
authors.lastname: Griffith
authors.affiliation: Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health.
authors.forename: Susan
authors.initials: S
authors.lastname: Goodin
authors.affiliation: Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health.
authors.forename: Robert
authors.initials: R
authors.lastname: DeChristoforo
authors.affiliation: Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health.
authors.forename: Capt Michael
authors.initials: CM
authors.lastname: Montello
authors.affiliation: Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health.
authors.forename: Judy L
authors.initials: JL
authors.lastname: Chase
authors.affiliation: Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health.
authors.forename: Sylvia
authors.initials: S
authors.lastname: Bartel
authors.affiliation: Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health.
authors.forename: Jharana Tina
authors.initials: JT
authors.lastname: Patel
mesh_terms: D000970:Antineoplastic Agents / Q000592:standards; D001691:Biological Therapy / Q000592:standards*; D004358:Drug Therapy / Q000592:standards*; D006801:Humans; D008508:Medication Errors / Q000517:prevention & control*; D010595:Pharmacists / Q000592:standards*; D010607:Pharmacy Service, Hospital / Q000592:standards*; D012957:Societies, Pharmaceutical / Q000592:standards*; D014481:United States
chemical_list: D000970:Antineoplastic Agents